Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI

Fuente: arXiv
Salvato in:
Dettagli Bibliografici
Autori principali: Liu, Hongbo, Li, Siyi, Yu, Zheng
Natura: Preprint
Pubblicazione: 2025
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866915464223916032
author Liu, Hongbo
Li, Siyi
Yu, Zheng
author_facet Liu, Hongbo
Li, Siyi
Yu, Zheng
contents Drug-drug interactions (DDIs) are a major concern in clinical practice, as they can lead to reduced therapeutic efficacy or severe adverse effects. Traditional computational approaches often struggle to capture the complex relationships among drugs, targets, and biological entities. In this work, we propose HGNN-DDI, a heterogeneous graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources. HGNN-DDI leverages graph representation learning to model heterogeneous biomedical networks, enabling effective information propagation across diverse node and edge types. Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness, highlighting its potential to support safer drug development and precision medicine.
format Preprint
id arxiv_https___arxiv_org_abs_2508_18766
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI
Liu, Hongbo
Li, Siyi
Yu, Zheng
Machine Learning
Primary 68T07, Secondary 68T05, 68R10, 92C50
I.2.6; I.5.1; H.2.8; J.3
Drug-drug interactions (DDIs) are a major concern in clinical practice, as they can lead to reduced therapeutic efficacy or severe adverse effects. Traditional computational approaches often struggle to capture the complex relationships among drugs, targets, and biological entities. In this work, we propose HGNN-DDI, a heterogeneous graph neural network model designed to predict potential DDIs by integrating multiple drug-related data sources. HGNN-DDI leverages graph representation learning to model heterogeneous biomedical networks, enabling effective information propagation across diverse node and edge types. Experimental results on benchmark DDI datasets demonstrate that HGNN-DDI outperforms state-of-the-art baselines in prediction accuracy and robustness, highlighting its potential to support safer drug development and precision medicine.
title Predicting Drug-Drug Interactions Using Heterogeneous Graph Neural Networks: HGNN-DDI
topic Machine Learning
Primary 68T07, Secondary 68T05, 68R10, 92C50
I.2.6; I.5.1; H.2.8; J.3
url https://arxiv.org/abs/2508.18766